Evidence map›Paper›PMID 42482457›Full record

ReviewPediatrics international : official journal of the Japan Pediatric Society

ACE2/Angiotensin 1-7/Mas Receptor Axis in Thermogenic Adipose Tissue: Age-Related Implications for Pediatric Obesity.

Jun Mori

Abstract readReview
In one paragraph

Review in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jun MoriDivision of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital, Osaka, Japan.

Funding

Japan Society for the Promotion of Science 15K08281Japan Society for the Promotion of Science 20K08165The Japanese Society for Pediatric Endocrinology
6 · The paper itself

Abstract

Pediatric obesity is a growing global health challenge, and effective and sustainable therapeutic options remain limited. Although lifestyle modifications remain the cornerstone of treatment, pharmacological and surgical interventions are restricted among pediatric populations, highlighting the need for novel pathophysiology-based strategies. Increasing evidence indicates that the renin-angiotensin system, particularly the nonclassical angiotensin-converting enzyme 2 (ACE2)/angiotensin 1-7 (Ang1-7)/Mas receptor (MasR) axis, plays an important role in metabolic regulation beyond classical cardiovascular functions. The ACE2/Ang1-7/MasR axis exerts pleiotropic metabolic effects, including anti-inflammatory and insulin-sensitizing actions, and has emerged as a key regulator of adipose tissue biology. Experimental studies have demonstrated that activation of this pathway stimulates brown adipose tissue (BAT), induces browning of white adipose tissue (WAT), and increases energy expenditure, thereby attenuating diet-induced obesity and attracting considerable attention as potential therapeutic targets. However, accumulating evidence from human imaging studies and experimental models suggests that BAT activity and thermogenic plasticity decline with age, which may affect the metabolic efficacy of interventions targeting thermogenic adipose tissue. Age-related differences in adipose tissue responsiveness may therefore contribute to discrepancies among previous studies examining Ang1-7-mediated thermogenic effects. This review summarized the current evidence regarding the role of the ACE2/Ang1-7/MasR axis in regulating thermogenic adipose tissue, with a focus on BAT activation and WAT browning in obesity. We further discuss age-related considerations that may modulate responsiveness to this pathway. Given that BAT activity is intrinsically high during childhood and adolescence, ACE2/Ang1-7 axis modulation may represent a promising therapeutic strategy for pediatric obesity.

Indexed as

Angiotensin IPediatric ObesityPeptide FragmentsPeptidyl-Dipeptidase AProto-Oncogene ProteinsReceptors, G-Protein-CoupledThermogenesisAdipose Tissue, BrownAge FactorsAngiotensin-Converting Enzyme 2AnimalsChildHumansProto-Oncogene MasRenin-Angiotensin SystemACE2 protein, humanAngiotensin-Converting Enzyme 2Angiotensin Iangiotensin I (1-7)Peptide FragmentsPeptidyl-Dipeptidase AProto-Oncogene MasProto-Oncogene ProteinsReceptors, G-Protein-CoupledACE2/Ang1‐7/MasR axisage‐dependent thermogenesisbrown adipose tissuepediatric obesitywhite adipose tissue browning

Identifiers

PMID42482457
PMCPMC13389330

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.